Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

Babar Basir: Importance of Multidisciplinary Care for Cardiogenic Shock

Babar Basir, DO, describes the importance of multidisciplinary care for patients with cardiogenic shock.

Babar Basir: Increased Use of Best Practices Since NCSI

Babar Basir, DO, highlights the increased use of acute mechanical circulatory support best practices since the National Cardiogenic Shock Initiative (NCSI) study.

Babar Basir: Importance of Door-To-Support in Cardiogenic Shock

Babar Basir, DO, discusses the evolving understanding of the importance of unloading with Impella® in patients with cardiogenic shock. 

Babar Basir: Predictors of Outcomes From NCSI

Babar Basir, DO, highlights trends and opportunities to improve outcomes using data from the National Cardiogenic Shock Initiative (NCSI) study.

Thursday Night Live: Putting the “I” Back in Team – Impella® Management in the ICU

Viktoriya Kagan, AGACNP-BC, CCRN, and Eddy Gutierrez, MD, discuss how to care for patients with cardiogenic shock and manage Impella® in the ICU.

Optimizing AMICS Patient Care Prior to Leaving the Cath Lab

Amir Kaki, MD, describes best practices and practical considerations for optimizing care of patients with AMI cardiogenic shock prior to leaving the cath lab.

HFSA 2021: Managing AMI Cardiogenic Shock Using the National Cardiogenic Shock Initiative Study Protocol

Babar Basir, DO, presents the National Cardiogenic Shock Initiative (NCSI) protocol for managing acute myocardial infarction cardiogenic shock (AMICS) at the 2021 HFSA scientific meeting.

Achieving >70% AMICS Survival: Insights From National Cardiogenic Shock Initiative Study

William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock. 

SCAI Shock Classification Helps Predict Survival in AMICS

Ivan Hanson, MD, explains the SCAI shock staging system and how it can predict survival in AMI cardiogenic shock.

A Story of Significant EF Improvement with Biventricular Impella® Support

To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.

How Do Bleeding Rates with Impella® Compare to Bleeding Rates Associated With Other Forms of Mechanical Circulatory Support?

This FAQ discusses bleeding rates associated with mechanical circulatory support and vascular access and closure techniques for successfully managing bleeding.

NCSI Study: About 40% of AMICS Patients Develop Right Ventricular Dysfunction

Babar Basir, DO, discusses NCSI study findings on right ventricular dysfunction in AMI cardiogenic shock.

Door-to-Unload (DTU) in STEMI Trial Summary: Pilot Trial and Pivotal Trial Design

Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.

Instituting a Cardiogenic Shock Protocol to Improve Outcomes

Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute. 

Heart Team Approach to Treating Cardiogenic Shock

Alexander Truesdell, MD, discusses best practices based on his team’s real-world experience treating cardiogenic shock.

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].